Table 1 Baseline clinical data of all patients
Variables | Decreased group (n = 354) | Preserved group (n = 362) | P |
|---|---|---|---|
Clinical characters | |||
Age (years) | 68.1 ± 7.5 | 63.7 ± 9.8 | < 0.001 |
Age ≥ 65 and < 75, n (%) | 177 (50.0) | 169 (46.7) | 0.374 |
Age ≥ 75, n (%) | 64 (18.1) | 33 (9.1) | < 0.001 |
male sex, n (%) | 220 (62.1) | 215 (59.4) | 0.450 |
BMI (kg/m2) | 24.77 ± 3.88 | 24.86 ± 3.41 | 0.761 |
Persistent AF, n (%) | 258 (72.9) | 65 (18) | < 0.001 |
Ischemic stroke, n (%) | 111 (31.4) | 56 (15.5) | < 0.001 |
Hypertension, n (%) | 241 (68.1) | 209 (57.7) | 0.004 |
CHF, n (%) | 112 (31.6) | 98 (27.1) | 0.272 |
Vascular disease, n (%) | 36 (10.2) | 37 (10.2) | 0.982 |
DM, n (%) | 78 (22) | 61 (16.9) | 0.080 |
Smoker, n (%) | 41 (11.6) | 46 (12.7) | 0.645 |
CHA2DS2-VASc score | 4 (2–5) | 2 (1–3) | < 0.001 |
Laboratory data | |||
WBC (x 109/L) | 6.09 ± 1.42 | 6.16 ± 1.46 | 0.510 |
HGB (g/L) | 140.36 ± 16.21 | 139.33 ± 16.42 | 0.399 |
PLT (x 109/L) | 195.28 ± 52.94 | 210.07 ± 54.95 | < 0.001 |
MPV (fL) | 11.22 ± 1.06 | 10.97 ± 1.11 | 0.002 |
FBG (mmol/L) | 5.06 (4.59–5.77) | 4.95 (4.55–5.54) | 0.167 |
HbA1c (%) | 5.8 (5.5–6.2) | 5.6 (5.4–6.1) | < 0.001 |
Cr (µmol/L) | 70 (60–82) | 67 (57–80) | 0.004 |
UA (µmol/L) | 367 (299–435) | 350 (296–416) | 0.033 |
BNP (pg/mL) | 226.9 ± 217.2 | 84.7 ± 103.4 | < 0.001 |
FFA (mmol/L) | 0.65 ± 0.32 | 0.69 ± 0.31 | 0.140 |
DD (ug/mL) | 0.18 ± 0.17 | 0.22 ± 1.04 | 0.554 |
Echocardiographic data | |||
LAD (mm) | 46.3 ± 4.9 | 41.1 ± 5.3 | < 0.001 |
LVEF (%) | 61 (55–65) | 64 (60–67) | < 0.001 |
LAAFV (m/s) | 0.27 (0.22–0.33) | 0.60 (0.48–0.78) | < 0.001 |